Steve Powell joins uMotif Board of Directors
London, UK - April 17, 2018 - We are delighted to announce the appointment of Steve Powell to the company's board of directors. Steve brings deep business development and industry expertise to uMotif's board having built some of the leading clinical platforms in use today.
Steve previously served as SVP of Global Sales for Phase Forward and was Chairman of Exco InTouch prior to their acquisition. Under Steve's leadership, Phase Forward grew sales to over $210m per annum, prior to their acquisition by Oracle. Steve currently chairs the board of MyMeds&Me, Cisiv and Dotmatics.
"It's a real coup for uMotif that Steve has joined our board of directors. He brings deep industry knowledge and understanding of how to deliver customer success in the clinical technology environment. We are delighted he has joined our board." said Bruce Hellman, CEO of uMotif.
Powell said “uMotif has game changing patient centric technology with applicability throughout the pharmaceutical product lifecycle, from clinical phases through launch and commercialisation and on to patient engagement for established medicines. To say nothing of the opportunity the platform holds to change how patients manage their disease. I am delighted to join the board and support uMotif's journey."
About Steve Powell
Steve is a board member of uMotif and Chairman and one of the founders of MyMeds&Me. Steve has extensive experience in the Pharmaceutical industry, having held senior positions in finance, IT, business development, commercial and manufacturing. Steve was instrumental in the establishment of Phase Forward as a global leader in the provision of software as a service (SaaS) to the Pharmaceutical industry prior to its sale.